HC Wainwright Estimates Alpha Cognition Q2 Earnings

Alpha Cognition Inc. (NASDAQ:ACOG) – Stock analysts at HC Wainwright issued their Q2 2027 earnings per share (EPS) estimates for Alpha Cognition in a research report issued on Wednesday, April 8th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings per share of ($0.10) for the quarter. HC Wainwright has a “Buy” rating and a $18.00 price objective on the stock.

Alpha Cognition (NASDAQ:ACOG) last released its earnings results on Thursday, March 26th. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03). Alpha Cognition had a negative net margin of 202.23% and a negative return on equity of 68.21%. The business had revenue of $2.60 million during the quarter, compared to analyst estimates of $4.41 million.

Separately, Wall Street Zen downgraded Alpha Cognition from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $18.00.

Alpha Cognition Stock Performance

Alpha Cognition stock opened at $6.64 on Thursday. Alpha Cognition has a one year low of $3.75 and a one year high of $11.54. The business has a fifty day moving average of $5.62 and a two-hundred day moving average of $6.08. The company has a market cap of $144.55 million, a P/E ratio of -5.72 and a beta of 2.51.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Berkshire Asset Management LLC PA raised its stake in shares of Alpha Cognition by 50.7% during the 3rd quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company’s stock worth $116,000 after buying an additional 6,000 shares during the last quarter. Villere ST Denis J & Co. LLC raised its stake in shares of Alpha Cognition by 13.2% during the 4th quarter. Villere ST Denis J & Co. LLC now owns 73,875 shares of the company’s stock worth $480,000 after buying an additional 8,617 shares during the last quarter. Green Alpha Advisors LLC acquired a new position in shares of Alpha Cognition during the 4th quarter worth $72,000. Geode Capital Management LLC acquired a new position in shares of Alpha Cognition during the 2nd quarter worth $112,000. Finally, Massar Capital Management LP acquired a new position in shares of Alpha Cognition during the 2nd quarter worth $116,000.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.